UroGen Pharma Future Growth
How is UroGen Pharma forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: URGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: URGN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: URGN is expected to become profitable in the next 3 years.
Revenue vs Market: URGN's revenue (36% per year) is forecast to grow faster than the US market (7% per year).
High Growth Revenue: URGN's revenue (36% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if URGN's Return on Equity is forecast to be high in 3 years time